コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 showed considerable improvement in cough and phlegm.
2 etric restriction, chronic cough and chronic phlegm.
4 6]; dry cough: 1.16 [1.01, 1.34]; persistent phlegm: 1.30 [1.07, 1.58]), but not with eczema (0.95 [0
5 h (odds ratio 1.9 [95% CI 1.2-2.9]), chronic phlegm (2.0 [1.3-3.0]), dyspnoea (2.3 [1.5-3.5]), asthma
6 SD, 16.0] years; 63% women; 17% smokers; 77% phlegm; 70% shortness of breath; 47% wheezing; 46% chest
7 identified 623 cases of incident cough with phlegm among 52,325 subjects by telephone interview from
8 identified 571 incident cases of cough with phlegm among the 49,140 cohort members with completed fo
9 garette smokers had considerably more cough, phlegm, and chronic wheeze and slightly more nasal catar
10 take at baseline and new onset of cough with phlegm in a population-based cohort of 63,257 middle-age
11 Bronchitic symptoms (bronchitis, cough, or phlegm in the past 12 mo) were ascertained via a questio
13 s may increase risk of developing cough with phlegm, independently of the apparent beneficial effects
15 was associated with nonchronic cough and/or phlegm (odds ratio (OR) = 1.19, 95% confidence interval
16 itively associated with new-onset cough with phlegm (odds ratio, 1.43; 95% confidence interval, 1.08,
17 s associated with asthma symptoms (cough and phlegm: odds ratio = 2.0; 95% CI = 1.4-2.86, P = .0001;
18 ides was associated with nonchronic cough or phlegm (OR = 1.14, 95% CI: 1.03, 1.27), chronic dry coug
19 hronic cough (OR, 1.9; P = 0.01) and chronic phlegm (OR, 1.5; P < 0.05), and to have increased risk o
20 chronic bronchitic symptoms (chronic cough, phlegm, or bronchitis) and of wheeze in the previous 12
21 y cough for 3 months in a row, congestion or phlegm other than when accompanied by a cold, or bronchi
22 nd fume exposures for chronic cough, chronic phlegm, persistent wheeze, and Global Initiative for Chr
23 or cough (RR: 12.4; 95% CI: 2.4 to 63.3) and phlegm production (RR: 7.8; 95% CI: 1.4 to 41.7), on any
24 eater declines in the incidence of cough and phlegm production from baseline to 52 weeks than did the
25 ce of symptoms than did referents for cough, phlegm production, Grades II and III dyspnea, and wheezi
27 strong association was found when cough and phlegm were included in bronchiectasis (OR, 0.72; 95% CI